How much is enough - surgical extent of initial parathyroidectomy and long-term outcomes in MEN1-related primary hyperparathyroidism
- 5 October 2026
- journal article
- research article
- Published by Springer Nature in Hormones
- p. 1-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysisThe Lancet Diabetes & Endocrinology, 2025
- Management of primary hyperparathyroidism in MEN1: From initial subtotal surgery to complex treatment of the remaining glandAnnales d'Endocrinologie, 2025
- Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Impact of genotype and surgical approach on long-term postoperative outcomesSurgery, 2023
- Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta‐AnalysisWorld Journal of Surgery, 2022
- Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidismScientific Reports, 2020
- Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1–primary hyperparathyroidismSurgery, 2013
- The Optimal Surgical Treatment for Primary Hyperparathyroidism in MEN1 Patients: A Systematic ReviewWorld Journal of Surgery, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Surgical Treatment of Hyperparathyroidism in Patients With Multiple Endocrine Neoplasia Type 1Archives of Surgery, 2005
- Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1Surgery, 2003